发明公开
EP2532390A2 Pharmaceutical composition for obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases
有权
Pharmazutische ZusammensetzungfürLeberkrankheiten。
- 专利标题： Pharmaceutical composition for obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases
- 专利标题（中）： Pharmazutische ZusammensetzungfürLeberkrankheiten。
-
申请号： EP12175609.2申请日： 2006-02-15
-
公开(公告)号： EP2532390A2公开(公告)日： 2012-12-12
- 发明人: Yoo, Sang-Ku , Park, Myunggyu , Jo, In Geum , Kwak, Tae-hwan
- 申请人： Md Bioalpha Co., Ltd.
- 申请人地址： 1713, Honor's Ville, 1380-1, Dunsan-dong, Seo-gu 302-120 Daejeon KR
- 专利权人： Md Bioalpha Co., Ltd.
- 当前专利权人： Md Bioalpha Co., Ltd.
- 当前专利权人地址： 1713, Honor's Ville, 1380-1, Dunsan-dong, Seo-gu 302-120 Daejeon KR
- 代理机构： Gillard, Richard Edward
- 优先权： KR20050012625 20050216
- 主分类号： A61P3/04
- IPC分类号： A61P3/04 ; A61P3/10 ; A61P3/00 ; A61P1/16 ; A61P9/10 ; A61P29/00 ; A61P27/02 ; A61P9/12 ; A61K31/352 ; A61K31/353 ; A61K31/343
摘要：
Provided is a pharmaceutical composition for the treatment and prevention of obesity, diabetes, metabolic syndromes, degenerative diseases and mitochondrial dysfunction-related diseases, comprising: a therapeutically effective amount of a compound represented by Formula I below, or a pharmaceutically acceptable salt, prodrug, solvate or isomer thereof, and a pharmaceutically acceptable carrier, a diluent or an excipient, or any combination thereof.
公开/授权文献
- EP2532390B1 Pharmaceutical composition for liver diseases. 公开/授权日：2016-08-17
信息查询
